CUAMC
VERA icon

China Universal Asset Management Company’s Vera Therapeutics VERA Stock Holding History

China Universal Asset Management Company’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Sell
11,424
-1,239
-10% -$46.2K 0.03% 268
2026
Q1 		$509K Buy
12,663
+2,246
+22% +$96.8K 0.04% 259
2025
Q4 		$528K Sell
10,417
-770
-7% -$27.3K 0.04% 255
2025
Q3 		$325K Sell
11,187
-1,622
-13% -$37.5K 0.03% 283
2025
Q2 		$302K Buy
12,809
+22
+0.2% +$495 0.03% 280
2025
Q1 		$307K Sell
12,787
-640
-5% -$20.6K 0.03% 284
2024
Q4 		$568K Buy
13,427
+2,882
+27% +$128K 0.05% 239
2024
Q3 		$466K Buy
10,545
+4,118
+64% +$156K 0.05% 228
2024
Q2 		$233K Sell
6,427
-3,690
-36% -$146K 0.03% 217
2024
Q1 		$436K Buy
10,117
+4,974
+97% +$177K 0.06% 195
2023
Q4 		$79.1K Buy
+5,143
New +$65.3K 0.02% 312

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

China Universal Asset Management Company's VERA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Vera Therapeutics (VERA) stake by 9.8% in Q2 2026, selling an estimated $46.2K and leaving 11,424 shares worth $490K. The position accounts for 0.03% of the portfolio, ranked #268.

China Universal Asset Management Company first reported a position in VERA in Q4 2023 and has held it in 11 quarters since. The position peaked at $568K in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • China Universal Asset Management Company held 11,424 shares of Vera Therapeutics worth $490K as of Q2 2026.
  • China Universal Asset Management Company sold 1,239 Vera Therapeutics shares in Q2 2026, an estimated $46.2K.
  • Vera Therapeutics made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #268 holding.
  • China Universal Asset Management Company first reported a position in Vera Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • China Universal Asset Management Company's Vera Therapeutics position peaked at $568K in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.